Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance
Go back to Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 102.77 -0.07 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.84 | 52 Week High | $39.41 | |||
| Open | $102.15 | 52 Week Low | $25.98 | |||
| Day High | $102.98 | P/E | 144.75 | |||
| Day Low | $100.57 | EPS | $0.71 | |||
| Volume | 267,918 | |||||
